Literature DB >> 18327087

Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.

Xiaoxia Wang1, Xuming Jia, Tuanjie Chang, Kaushik Desai, Lingyun Wu.   

Abstract

OBJECTIVES: Methylglyoxal is a reactive dicarbonyl intermediate of metabolism produced in the body. It reacts with certain proteins and forms damaging advanced glycation endproducts (AGEs) such as N epsilon-carboxyethyl-lysine (CEL) and N epsilon-carboxymethyl-lysine (CML). Increased methylglyoxal levels are found in diabetes mellitus and associated with hypertension development in the spontaneously hypertensive rats (SHR). The purpose of this study was to investigate whether increased endogenous formation of methylglyoxal and methylglyoxal-induced AGEs caused hypertension development in normotensive Sprague Dawley rats.
METHODS: The rats were fed chronically for 16 weeks with fructose, a known precursor of methylglyoxal formation. One group of rats was cotreated with fructose and metformin, an AGEs formation inhibitor. Methylglyoxal and reduced glutathione (GSH) were measured by high performance liquid chromatography, whereas hydrogen peroxide was measured by a dicholorofluorescin assay. Immunohistochemistry was performed for endothelial nitric oxide synthase (eNOS), CEL and CML.
RESULTS: Fructose-fed rats had elevated blood pressure, serum methylglyoxal and triglycerides and reduced serum levels of GSH. Methylglyoxal, hydrogen peroxide and CEL were increased in the aorta, whereas eNOS was reduced. CEL and CML were also increased in the mesenteric artery endothelium along with media/lumen ratio, signifying structural remodelling. All the harmful changes in fructose-fed rats were attenuated in metformin and fructose cotreated rats.
CONCLUSION: Increased methylglyoxal, AGEs, oxidative stress and reduced eNOS along with structural remodeling of the vessel wall in the aorta and mesenteric artery likely play a role in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327087     DOI: 10.1097/HJH.0b013e3282f4a13c

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  31 in total

1.  Decreased Gluconeogenesis in the Absence of Cystathionine Gamma-Lyase and the Underlying Mechanisms.

Authors:  Ashley A Untereiner; Rui Wang; YoungJun Ju; Lingyun Wu
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

2.  Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo.

Authors:  Cecilia Nigro; Gregory A Raciti; Alessia Leone; Thomas H Fleming; Michele Longo; Immacolata Prevenzano; Francesca Fiory; Paola Mirra; Vittoria D'Esposito; Luca Ulianich; Peter P Nawroth; Pietro Formisano; Francesco Beguinot; Claudia Miele
Journal:  Diabetologia       Date:  2014-04-24       Impact factor: 10.122

3.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

Review 4.  Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.

Authors:  Alejandro Gugliucci
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

5.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Anne M Dorrance; Kouros Motamed; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

6.  Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats.

Authors:  Arti Dhar; Kaushik M Desai; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

7.  Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress.

Authors:  O Brouwers; P M Niessen; G Haenen; T Miyata; M Brownlee; C D Stehouwer; J G De Mey; C G Schalkwijk
Journal:  Diabetologia       Date:  2010-02-26       Impact factor: 10.122

Review 8.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

Review 9.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

10.  Soluble receptor for advanced glycation end products mitigates vascular dysfunction in spontaneously hypertensive rats.

Authors:  Yu Liu; Manli Yu; Le Zhang; Qingxin Cao; Ying Song; Yuxiu Liu; Jianbin Gong
Journal:  Mol Cell Biochem       Date:  2016-07-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.